Isaac Francis

The Reserve Bank of Australia has signalled that interest rates may need to be raised further to return inflation to the target range.

UroGen Pharma (NASDAQ:URGN) received United States FDA clearance for its Investigational New Drug application to initiate clinical evaluations of its next-generation oncolytic virus treatment UGN-501.

Odysight.ai (NASDAQ:ODYS) received a purchase order valued at approximately $0.3 million (NIS 1.0 million) from Elbit Systems to supply its specialized health monitoring software.

BioLineRx (NASDAQ:BLRX) and Hemispherian reported positive preclinical data from a patient-derived ovarian cancer xenograft model showing a strong therapeutic synergy between its small-molecule candidate GLIX1 and the approved PARP inhibitor olaparib.

Satellos Bioscience (NASDAQ:MSLE) reported positive six-month interim data from its open-label Phase 2 TRAILHEAD clinical study evaluating its investigational oral drug candidate SAT-3247 in adults with Duchenne muscular dystrophy.

Energy giant Shell (NYSE:SHEL) finalized a $1 billion agreement to sell its entire downstream network of 580 petrol stations across South Africa to the Abu Dhabi National Oil Company.

Bitcoin Suisse has secured full Financial Services Permission from the Financial Services Regulatory Authority of Abu Dhabi Global Market, allowing its subsidiary to provide regulated cryptocurrency services to institutional clients across the United Arab Emirates.

XRP (CRYPTO:XRP) is showing growth across tokenised assets, investment flows and user activity, with XRP treasury company Evernorth reporting about US$4 billion in tokenised real-world assets on the XRP Ledger.

IFM Investors finalised its takeover of Atlas Arteria (ASX:ALX) overnight, securing a 67.43% stake in the firm.

Solana (CRYPTO:SOL) recorded US$8.68 billion in real-world asset transfer volume over the past 30 days, up 105.76% from a month earlier.